Antiplatelet therapy, Helicobacter pylori infection and complicated peptic ulcer disease in diabetes: The Fremantle Diabetes Study

Diabetic Medicine

Volumn 26, Issue 1, 2009, Pages 70-75

  Schimke, K ^a   Chubb, S A P ^b   Davis, W A ^a   Phillips, P ^c   Davis, T M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Helicobactor pylori; Peptic ulcer disease; Serological testing; Upper gastrointestinal haemorrhage

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; IMMUNOGLOBULIN G; SULFONYLUREA; UREA;

ADULT; ANTICOAGULANT THERAPY; ARTERY DISEASE; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DUODENAL ULCER BLEEDING; DUODENUM BLEEDING; ETHNICITY; FEMALE; HELICOBACTER INFECTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; RISK FACTOR; SCREENING; SEROLOGY; STOMACH HEMORRHAGE; UREA BLOOD LEVEL;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPTIC ULCER; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SEROLOGIC TESTS; WESTERN AUSTRALIA;

EID: 58149232413     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02637.x     Document Type: Article

References (30)

1. Hennekens CH. Update on aspirin in the treatment and prevention of cardiovascular disease. Am J Manag Care 2002 8 : S691 700.
2. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006 119 : 624 638.
3. Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007 23 : 163 173.
4. Limmer S, Ittel TH, Wietholtz H. Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios. Z Gastroenterol 2003 41 : 719 728.
5. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes Care 2007 30 : S4 41.
6. Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 2002 13 : 376 379.
7. Dore MP, Bilotta M, Malaty HM, Pacifico A, Maioli M, Graham DY et al. Diabetes mellitus and Helicobacter pylori infection. Nutrition 2000 16 : 407 410.
8. Xia HH-X, Talley NJ, Kam EPY, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001 96 : 1039 1046.
9. Marrollo M, Latella G, Melideo D, Storelli E, Iannarelli R, Stornelli P et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis 2001 33 : 21 29.
10. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001 32 : 215 217.
11. Weil J, Langman MJS, Wainwright P, Lawson DH, Rawlins M, Logan RFA et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000 46 : 27 31.
12. Thomsen RW, Riis A, Christensen S, Norgaard M, Sorensen HT. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 2006 29 : 805 810.
13. Davis TME, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multiethnic Australian community: the Fremantle Diabetes Study. Diabet Med 2000 17 : 667 674.
14. Norman PE, Davis WA, Bruce DG, Davis TM. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2006 29 : 575 580.
15. Laheij RJ, Straatman H, Jansen JB, Verbeek AL. Evaluation of commercially available Helicobacter pylori serology kits: a review. J Clin Microbiol 1998 36 : 2803 2809.
16. Ongey M, Brenner H, Thefeld W, Rothenbacher D. Helicobacter pylori and hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 2004 11 : 471 476.
17. Coles KA, Knuiman MW, Plant AJ, Riley TV, Smith DW, Divitini ML. A prospective study of infection and cardiovascular diseases: the Busselton Health Study. Eur J Cardiovasc Prev Rehabil 2003 10 : 278 282.
18. Magalhaes Queiroz DM, Luzza F. Epidemiology of Helicobacter pylori infection. Helicobacter 2006 11 (Suppl 1 1 5.
19. Cullen DJ, Collins BJ, Christiansen KJ, Epis J, Warren JR, Surveyor I et al. When is Helicobacter pylori infection acquired? Gut 1993 34 : 1681 1682.
20. Wood M. Chronic peptic ulcer in 94 diabetics. Am J Digest Dis 1947 14 : 1.
21. Klebl FH, Bregenzer N, Schöfer L, Tamme W, Langgartner J, Schölmerich J et al. Comparison of inpatient and outpatient upper gastrointestinal haemorrhage. Int J Colorectal Dis 2005 20 : 368 375.
22. Longstreth G. Epidemiology of hospitalization for acute upper gastrointestinal haemorrhage: a population-based study. Am J Gastroenterol 1995 90 : 206 210.
23. Faigel DO, Metz DC. Prevalence, aetiology, and prognostic significance of upper gastrointestinal haemorrhage in diabetic ketoacidosis. Dig Dis Sci 1996 41 : 1 8.
24. Leerdam ME, Vreeburg EM, Rauws EAJ, Geraedts AAM, Tijssen JGP, Reitsma JB et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003 98 : 1494 1499.
25. Harsch IA, Brzozowski T, Bazela K, Konturek SJ, Kukharsky V, Pawlik T et al. Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines. Eur J Pharmacol 2003 481 : 249 260.
26. Miura S. Decreased gastric mucosal barrier function in diabetes mellitus. J Gastroenterol 1999 34 : 288 291.
27. Siluk D, Kaliszan R, Haber P, Petrusewicz J, Brzozowski Z, Sut G. Antiaggregatory activity of hypoglycaemic sulphonylureas. Diabetologia 2002 45 : 1034 1037.
28. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007 3 : 138 153.
29. Pumphrey CW, Beck ER. Raised blood urea concentration indicates considerable blood loss in acute upper gastrointestinal haemorrhage. BMJ 1980 280 : 527 528.
30. Kang JY, Elders A, Majeed A, Maxwell JD, Bardhan KD. Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther 2006 24 : 65 79.